Zephyrnet Logo

Tag: effector

Ceria-vesicle nanohybrid therapeutic for modulation of innate and adaptive immunity in a collagen-induced arthritis model – Nature Nanotechnology

Firestein, G. S. Evolving concepts of rheumatoid arthritis. Nature 423, 356–361 (2003).Article  CAS  Google Scholar  McInnes, I. B. & Schett, G. The pathogenesis...

Latest Piorun MANPADS brings new seeker, computing systems

18 September 2023 by Jakub Link-Lenczowski Piorun MANPADS – the Next Generation system is intended to be...

Aug. 22 Quick Takes: Forty51-backed Mysthera launches to development autoimmune therapies

ARTICLE | FinancePlus: FDA lifts hold on Fulcrum’s trial and more, panel to discuss Geron’s imetelstat By BioCentury Staff August 22, 2023 11:52 PM UTC Basel-based Mysthera...

Scientists elaborated the design and application prospect of China’s

As a manned spacecraft operating in orbit for a long time, a space station embodies a country’s scientific and technological strength comprehensively. China’s manned...

FDA Approves Talvey (talquetamab-tgvs), a First-in-Class Bispecific Therapy for the Treatment of Patients with Heavily Pretreated Multiple Myeloma

FDA Approves Talvey (talquetamab-tgvs), a First-in-Class Bispecific Therapy for the Treatment of Patients with Heavily Pretreated Multiple MyelomaHORSHAM, Pa., Aug. 10, 2023 – The...

SNIP1 and PRC2 coordinate cell fates of neural progenitors during brain development – Nature Communications

SNIP1 is required for the survival of NPCs in the murine embryonic brainWe first examined the expression of Snip1 in the murine embryonic brain...

Marines want $200M for powerful drone-killing machines

By fall 2024, Marine Corps low altitude air defense battalions will begin receiving a powerful new weapon: Marine air defense integrated systems, or L-MADIS,...

Coya Therapeutics Reports Additional Biomarker and Imaging Data Showing Decrease in Neuroinflammation with COYA 301 in Alzheimer’s Disease.

Highlights Coya reports new data illustrating that administration of COYA 301 (low dose Interleukin-2 (IL-2)) in an open- label study in 8 patients with...

Latest Intelligence

spot_img
spot_img